PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage

Cell Death and Differentiation

Volumn 23, Issue 9, 2016, Pages 1448-1457

  Barroso Gonzalez J ^a   Auclair, S ^a   Luan, S ^a   Thomas, L ^a   Atkins, K M ^b   Aslan, J E ^c   Thomas, L L ^a   Zhao, J ^a   Zhao, Y ^a   Thomas, G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PROTEIN; PROTEIN BCL XL; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PACS2 PROTEIN, MOUSE; PROTEIN BCL X; TUMOR NECROSIS FACTOR; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL SURVIVAL; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; GENOTOXICITY; IN VIVO STUDY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RADIATION DOSE; SIGNAL TRANSDUCTION; THYMOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; HCT 116 CELL LINE; HUMAN; IONIZING RADIATION; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRIAL MEMBRANE; RADIATION RESPONSE;

ANIMALS; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BCL-X PROTEIN; CASPASE 3; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; HCT116 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANES; NF-KAPPA B; RADIATION, IONIZING; SIGNAL TRANSDUCTION; THYMOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VESICULAR TRANSPORT PROTEINS;

EID: 84959556923     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2016.23     Document Type: Article

References (59)

1. Napetschnig J, Wu H. Molecular basis of NF-kappaB signaling. Annu Rev Biophys 2013; 42: 443-468.
2. Chen C, Edelstein LC, Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol. 2000; 20: 2687-2695.
3. Thomenius MJ, Distelhorst CW. Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance. J Cell Sci 2003; 116 (Pt 22): 4493-4499.
4. Eno CO, Eckenrode EF, Olberding KE, Zhao G, White C, Li C. Distinct roles of mitochondriaand ER-localized Bcl-xL in apoptosis resistance and Ca2+ homeostasis. Mol Biol Cell 2012; 23: 2605-2618.
5. Billen LP, Kokoski CL, Lovell JF, Leber B, rews DW. Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol. 2008; 6: e147.
6. Li C, Fox CJ, Master SR, Bindokas VP, Chodosh LA, Thompson CB. Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc Natl Acad Sci USA 2002; 99: 9830-9835.
7. Distelhorst CW, Bootman MD. Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2+) signaling and disease. Cell Calcium 2011; 50: 234-241.
8. Yu J, Zhang L. PUMA, a potent killer with or without p53. Oncogene 2008; 27(Suppl 1): S71-S83.
9. Follis AV, Chipuk JE, Fisher JC, Yun MK, Grace CR, Nourse A et al. PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis. Nat Chem Biol 2013; 9: 163-168.
10. Xiao G, Fu J. NF-kappaB and cancer: a paradigm of Yin-Yang. Am J Cancer Res 2011; 1: 192-221.
11. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999; 274: 30353-30356.
12. Israel A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010; 2: a000158.
13. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel AE. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol 2000; 165: 1743-1754.
14. Xu RX, Liu RY, Wu CM, Zhao YS, Li Y, Yao YQ et al. DNA damage-induced NF-kappaB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation. Cell Physiol Biochem 2015; 35: 913-925.
15. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009; 27: 693-733.
16. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NFkappaB signaling in response to genotoxic stimuli. Science 2006; 311: 1141-1146.
17. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit C. A cytoplasmic ATMTRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kappaB activation. Mol Cell 2010; 40: 63-74.
18. Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, Miyamoto S et al. ATM-and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell 2010; 40: 75-86.
19. Yang Y, Xia F, Hermance N, Mabb A, Simonson S, Morrissey S et al. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol 2011; 31: 2774-2786.
20. Aslan JE, You H, Williamson DM, Endig J, Youker RT, Thomas L et al. Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis. Mol Cell 2009; 34: 497-509.
21. Atkins KM, Thomas L, Youker RT, Harriff MJ, Pissani F, You H et al. HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice. J Biol Chem 2008; 283: 11772-11784.
22. Dikeakos JD, Thomas L, Kwon G, Elferich J, Shinde U, Thomas G. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I. Mol Biol Cell 2012; 23: 2184-2197.
23. Dombernowsky SL, Samsoe-Petersen J, Petersen CH, Instrell R, Hedegaard AM, Thomas L et al. The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17. Nat Commun 2015; 6: 7518.
24. Kottgen M, Benzing T, Simmen T, Tauber R, Buchholz B, Feliciangeli S et al. Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. EMBO J 2005; 24: 705-716.
25. Myhill N, Lynes EM, Nanji JA, Blagoveshchenskaya AD, Fei H, Carmine Simmen K et al. The subcellular distribution of calnexin is mediated by PACS-2. Mol Biol Cell 2008; 19: 2777-2788.
26. Werneburg NW, Bronk SF, Guicciardi ME, Thomas L, Dikeakos JD, Thomas G et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2). J Biol Chem 2012; 287: 24427-24437.
27. Simmen T, Aslan JE, Blagoveshchenskaya AD, Thomas L, Wan L, Xiang Y et al. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J 2005; 24: 717-729.
28. Atkins KM, Thomas LL, Barroso-Gonzalez J, Thomas L, Auclair S, Yin J et al. The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest. Cell Rep 2014; 8: 1545-1557.
29. Barroso-Gonzalez J, Thomas G. Endosome traffic machinery meets the p53-p21 axis. Mol Cell Oncol 2015; 2: e975075.
30. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Bcl-XL Korsmeyer SJ. and Bcl-2 repress a common pathway of cell death. J Exp Med 1995; 182: 821-828.
31. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999; 18: 6867-6874.
32. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49-62.
33. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380.
34. Li N, Banin S, Ouyang H, Li GC, Courtois G, Shiloh Y et al. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J Biol Chem 2001; 276: 8898-8903.
35. Zhou D, Brown SA, Yu T, Chen G, Barve S, Kang BC et al. A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo. Radiat Res 1999; 151: 703-709.
36. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM et al. IkappaB-kinasebetadependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 2004; 101: 2452-2457.
37. Wang Y, Meng A, Lang H, Brown SA, Konopa JL, Kindy MS et al. Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiationinduced damage. Cancer Res 2004; 64: 6240-6246.
38. Wuerzberger-Davis SM, Chang PY, Berchtold C, Miyamoto S. Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction. Mol Cancer Res 2005; 3: 345-353.
39. So EY, Ouchi T. Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK catalytic subunit. Exp Ther Med 2011; 2: 443-447.
40. So EY, Ouchi T. BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction. BMC Cancer 2014; 14: 548.
41. Guicciardi ME, Werneburg NW, Bronk SF, Franke A, Yagita H, Thomas G et al. Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity. PLoS One 2014; 9: e92124.
42. Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 2013; 339: 1216-1219.
43. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, more. Nat Rev Mol Cell Biol 2013; 14: 197-210.
44. Berchtold CM, Wu ZH, Huang TT, Miyamoto S. Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli. Mol Cell Biol 2007; 27: 497-509.
45. McCool KW, Miyamoto S. DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out. Immunol Rev 2012; 246: 311-326.
46. Ambrose M, Goldstine JV, Gatti RA. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet 2007; 16: 2154-2164.
47. Ismail F, Ikram M, Purdie K, Harwood C, Leigh I, Storey A. Cutaneous squamous cell carcinoma (SCC) and the DNA damage response: pATM expression patterns in premalignant and malignant keratinocyte skin lesions. PLoS One 2011; 6: e21271.
48. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS et al. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 1998; 95: 10146-10151.
49. Watters D, Kedar P, Spring K, Bjorkman J, Chen P, Gatei M et al. Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem 1999; 274: 34277-34282.
50. Zhang L, Tie Y, Tian C, Xing G, Song Y, Zhu Y et al. CKIP-1 recruits nuclear ATM partially to the plasma membrane through interaction with ATM. Cell Signal 2006; 18: 1386-1395.
51. Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L et al. EGFR-induced and PKCepsilon monoubiquitylation-dependent NF-kappaB activation upregulates PKM2 expression and promotes tumorigenesis. Mol Cell 2012; 48: 771-784.
52. Lee HJ, Lan L, Peng G, Chang WC, Hsu MC, Wang YN et al. Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response. Cell Res 2015; 25: 225-236.
53. Copley SD. Moonlighting is mainstream: paradigm adjustment required. BioEssays 2012; 34: 578-588.
54. Sieburth D, Ch'ng Q, Dybbs M, Tavazoie M, Kennedy S, cWang D et al. Systematic analysis of genes required for synapse structure and function. Nature 2005; 436: 510-517.
55. Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN. Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci USA 2013; 110: 12526-12534.
56. Dikeakos JD, Atkins KM, Thomas L, Emert-Sedlak L, Byeon IJ, Jung J et al. Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 2010; 21: 3279-3292.
57. Youker RT, Shinde U, Day R, Thomas G. At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem J 2009; 421: 1-15.
58. Lu WJ, Amatruda JF, Abrams JM. p53 ancestry: gazing through an evolutionary lens. Nature Rev Cancer 2009; 9: 758-762.
59. Yu J, Zhang L. No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 2003; 4: 248-249.